USPTO serial 79267756
CONSORT MEDICAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 9, 2020
- Examiner
- MCBRIDE, CAMERON L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CONSORT MEDICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*
Plus Government fees of $2,550
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Hertfordshire, GB
Hertfordshire, GB
Hertfordshire, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Max Vern
Max Vern Amster, Rothstein & Ebenstein LLP90 Park AvenueNew York, NY 10016UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals and pharmaceutical preparations for the treatment of dermatological, cardiovascular, haematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders, drug addiction and opioid addiction; active pharmaceutical ingredients in the form of tablets, liquids, powders and skin patches and coatings for tablets and powders that facilitate the delivery of pharmaceuticals | ACTIVE | — |
| 010 | Medical apparatus and instruments for the delivery of drugs and medicines; drug delivery devices; inhalers for medical use; metered dose inhalers for medical use; dry powder inhalers for medical use; inhaled drug delivery apparatus and instruments in the nature of a drug delivery system; hydrofluoralkanes (HFA) powered infusion and injection devices, systems, apparatus and instruments for use in drug and pharmaceutical delivery; hydrofluoralkanes (HFA) powered syringes, auto-injectors and injection devices for administrating pharmaceuticals and drugs; hydrofluoralkanes (HFA) powered infusion and injection devices, systems, apparatus and instruments for use in drug and pharmaceutical delivery incorporating audio, visual and/or tactile feedback mechanisms relating to drug and pharmaceutical delivery; hydrofluoralkanes (HFA) powered syringes, auto-injectors and injection devices for administrating pharmaceuticals and drugs incorporating audio, visual and tactile feedback mechanisms relating to drug and pharmaceutical delivery; syringes; syringe stoppers specially adapted for medical syringes; auto-injectors for pharmaceuticals; medical injectors for pharmaceuticals; disposable medical syringes and injectors; hypodermic syringes and injectors for pharmaceuticals; infusion and injection devices for administering pharmaceuticals and drugs; sterile apparatus for the administration of pharmaceuticals and drugs; cartridges specially adapted for medical syringes; nozzles specially adapted for medical syringes; drug delivery systems; oral and nasal medication aerosol dispensers; aerosol dispensers for medical purposes; parts and fittings for all the aforesaid; valves, pumps and actuators specially adapted for medical dispensers aerosols and powders; valves, pumps and actuators specially adapted for use in medical dispensers inhalers and drug dispensing and delivery systems; parts and fittings for all the aforesaid goods; elastomer parts for valves, pumps and actuators, specially adapted for medical apparatus and instruments for the delivery of drugs and medicines and for drug delivery systems | ACTIVE | — |
| 017 | Gaskets made of rubber or imitation rubber for use in systems for the delivery of drugs and medicines; non-metal gaskets for medical use | ACTIVE | — |
| 040 | Custom manufacture of medical apparatus and instruments, inhalers and drug delivery products, pharma and medical products and apparatus; custom manufacture of components, parts and fittings for all the aforesaid products; management of product lifecycles for others, in the nature of custom manufacturing of medical apparatus and instruments, inhalers and drug delivery products, pharma and medical products and apparatus; provision of injection moulding services of plastic for others; custom manufacture of active pharmaceutical ingredients for others; custom manufacture of pharmaceuticals for others; advisory, consultancy and information services relating to all the aforesaid | ACTIVE | — |
| 041 | Provision of training, teaching and educational services in the nature of classes and tutorials all in the field of the delivery of drugs, pharmaceuticals and medicines; advisory, consultancy and information services relating to all the aforesaid | ACTIVE | — |
| 042 | Product design and development of medical apparatus and instruments for others; product design and development of inhalers and drug delivery products for others; product design and development of pharmaceuticals, pharma and medical products and apparatus for others; prototyping services namely the development and manufacture of prototype products for use in the medical industry; metrology services; scientific laboratory services in the field of analytic testing; product quality testing services; quality control advisory services namely regulatory quality control advisory services in the field of pharmaceuticals, active pharmaceutical ingredients, medical apparatus and instruments, inhalers and drug delivery products, pharma and medical products and apparatus; management of product lifecycles for others, in the nature of conducting and managing clinical trials and trials of medical apparatus and instruments, inhalers and drug delivery products, pharma and medical products and apparatus; advisory, consultancy and information services relating to all the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Consort Medical Plc
- Other trademarks owned by Consort Medical Plc
- Other trademarks owned by Consort Medical Plc
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 017
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named CONSORT MEDICAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 9, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 18, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 30, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 30, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 9, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 13, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 9, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 24, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 24, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 4, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 18, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 16, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 28, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 28, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 9, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 8, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 1, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 1, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 19, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |